Well I am expecting triple failure of all their trials this fall(NSCLC 1st & 2nd line, Pancreatic). I will be smiling then.
I think it is important not to let one's investment views or positions color the fact that we are dealing with drugs that can actually help patients. A failure of a drug trial is never a reason to smile.